Suppr超能文献

线粒体分裂抑制剂MDIVI-1对未控制出血性休克大鼠的器官功能具有保护作用并延长了治疗窗。

THE MITOCHONDRIAL DIVISION INHIBITOR MDIVI-1 PROTECTED ORGAN FUNCTION AND EXTENDED THE TREATMENT WINDOW IN RATS WITH UNCONTROLLED HEMORRHAGIC SHOCK.

作者信息

Hu Yi, Fang He, Tan Lei, She Han, Du Yuanlin, Zhu Yu, Wu Yue, Liu Liangming, Li Tao

机构信息

Department of Anaesthesiology, Daping Hospital, Army Medical University, Chongqing, China.

State Key Laboratory of Trauma, Burns and Combined Injury, Shock and Transfusion Department, Daping Hospital, Army Medical University, Chongqing, China.

出版信息

Shock. 2025 Mar 1;63(3):474-486. doi: 10.1097/SHK.0000000000002459. Epub 2024 Aug 26.

Abstract

Aim: This study aimed to elucidate whether the application of the mitochondrial division inhibitor Mdivi-1 can protect organ function and prolong the treatment window for traumatic hemorrhagic shock. Methods: Before definitive hemostasis treatment, Mdivi-1 (0.25 mg/kg, 0.5 mg/kg, and 1 mg/kg) was administered to uncontrolled hemorrhagic shock (UHS) model rats. Lactate Ringer's solution plus hydroxyethyl starch (130/0.4) was used as a control. The effects of Mdivi-1 on blood loss; fluid demand; survival time; vital organ function; myocardial mitochondrial structure; mitochondrial function of the heart, liver, kidney, and intestine; and oxidative stress at 1 h after hypotensive resuscitation (50-60 mm Hg) were investigated. In addition, we investigated the effect of varying doses of Mdivi-1 on the maintenance time of hypotensive resuscitation without definitive hemostasis and the beneficial effect of Mdivi-1 after prolonging the duration of hypotensive resuscitation to 2 h. Results: Compared to conventional resuscitative fluid, Mdivi-1 significantly reduced blood loss and fluid demand, improved important organ functions during hypotensive resuscitation, improved animal survival, and reduced the incidence of early death. Mdivi-1 significantly alleviated oxidative stress injury, reduced mitochondrial damage, and restored myocardial mitochondrial structure and mitochondrial function of the heart, liver, kidney, and intestine. In addition, Mdivi-1 increased the maintenance time of hypotensive resuscitation and improved rat survival after the duration of hypotensive resuscitation was prolonged to 2 h. Conclusion: Mdivi-1 significantly prolonged the treatment window for traumatic hemorrhagic shock to 2 h in UHS model rats. The underlying mechanism may be that Mdivi-1 inhibits excessive mitochondrial fission and oxidative stress and improves the structure and function of mitochondria.

摘要

目的

本研究旨在阐明线粒体分裂抑制剂Mdivi-1的应用是否能保护器官功能并延长创伤性失血性休克的治疗窗。方法:在确定性止血治疗前,将Mdivi-1(0.25毫克/千克、0.5毫克/千克和1毫克/千克)给予未控制出血性休克(UHS)模型大鼠。使用乳酸林格氏液加羟乙基淀粉(130/0.4)作为对照。研究了Mdivi-1对失血、液体需求量、存活时间、重要器官功能、心肌线粒体结构、心脏、肝脏、肾脏和肠道的线粒体功能以及低血压复苏(50-60毫米汞柱)后1小时氧化应激的影响。此外,我们研究了不同剂量的Mdivi-1对无确定性止血的低血压复苏维持时间的影响以及将低血压复苏持续时间延长至2小时后Mdivi-1的有益作用。结果:与传统复苏液相比,Mdivi-1显著减少了失血和液体需求量,改善了低血压复苏期间的重要器官功能,提高了动物存活率,并降低了早期死亡的发生率。Mdivi-1显著减轻了氧化应激损伤,减少了线粒体损伤,并恢复了心脏、肝脏、肾脏和肠道的心肌线粒体结构和线粒体功能。此外,Mdivi-1增加了低血压复苏的维持时间,并在将低血压复苏持续时间延长至2小时后提高了大鼠存活率。结论:在UHS模型大鼠中,Mdivi-1显著将创伤性失血性休克的治疗窗延长至2小时。其潜在机制可能是Mdivi-1抑制过度的线粒体分裂和氧化应激,并改善线粒体的结构和功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03dd/11882165/c0eee9582a9a/shock-63-474-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验